Top Headlines
- Bug bidders to bite? Sanofi give-back opens door to replacement partner for Kalobios
- Targacept tanks after TC-5214 goes down the drain
- Taiho, Sumitomo commit $30M each to build new Remiges VC fund
- Combination treatment increases effects of cancer immunotherapy
- Canbridge's 'portfolio' bid aims to get cancer drugs to patients faster
Latest News
Analysis
No one in biotech – industry, academia, regulators, nonprofits or patients themselves – disputes that cancer drug development is at a critical juncture. A raft of young companies has joined early movers in the space and the pipeline is filled with promising drugs.
Our Habitat for All Things Science
Browning of white fat is key to onset of weight loss in cancer
LONDON – Cachexia, the wasting syndrome that is responsible for many deaths among people with cancer, occurs because – among other changes in the body – white adipose tissue (WAT) switches to become brown adipose tissue (BAT), a new study has found.
READ MORE »- Combination treatment increases effects of cancer immunotherapy »
- Researchers discover genetic cause of common breast tumors »
- Enzyme family works via many mechanisms »
- Genetic influence on puberty intertwined with growth control genes »
- Pre-eclampsia joins the roster of protein-folding disorders »
- New research findings, $650M cash pledge to bolster psychiatric space »
- Fatty acid transport protein defects linked to schizophrenia, autism »
- Study points to new promising Alzheimer's disease treatment »
- New method for organ preservation gives gift of time to surgeons »
Featured Report
Opinion
- A little irony here? FDA’s technical difficulties on social media webinar send folks a’Twitter’July 10, 2014 | 9:44 PM | Posted by: Marie Powers
- Old news, yet still making headlinesJune 13, 2014 | 4:11 PM | Posted by: Mari Serebrov
- Pigoons, politicians and the periodic table: BioWorld’s 8th annual biotech summer reading listJune 06, 2014 | 4:09 PM | Posted by: Marie Powers
- ASCO strides provide cold comfortJune 05, 2014 | 4:38 PM | Posted by: Randy Osborne
- Capturing cancer drugs' true value calls for clear thinkingMay 30, 2014 | 3:48 PM | Posted by: Michael Fitzhugh
Partners in Focus
